‘Access is not simply about opening the door to another provider,’ she said. ‘True access is about removing every barrier between a patient and that provider.’ 
Strengthening cardiovascular care through pharmacy expertise
Natalie Raffoul leverages her pharmacy skills in public health, leading national initiatives that improve cardiovascular care.
Resistance movement: Pharmacy’s fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Gut fermentation of dietary fibres: implications for health
Studies have demonstrated a link between low levels of dietary fibre and the occurrence of chronic diseases including type 2 diabetes and cardiovascular disease.
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
